Der er ingen kontrollerede undersøgelser, undtagen hos nyligt diagnosticerede kronisk fase CML- patienter, der har vist klinisk bedring såsom forbedring af sygdomsrelaterede symptomer eller øget overlevelse.
Except in newly diagnosed chronic phase CML, there are no controlled trials demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival.